Abstract
• We examined psychotropic drug use in children with ADHD and anxiety. • The overall follow-up time was occupied almost evenly by no treatment (∼30%), mono-(∼40%) and combination pharmacotherapy (∼30%). • Treatment prevalence of ADHD outweighed treatment of anxiety. • Both clinical and non-clinical factors had impact on combination pharmacotherapy. • Significant treatment differences exist among the 26 US study states.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
